Aurora sets out to capitalize on FDA’s new framework for bespoke drug therapies In the News Jan 9 Written by Christine Mackenzie Christine Mackenzie Previous Previous JPM 2026: Aurora Therapeutics’ Edward Kaye on Scalable Personalized Gene Editing Next Next Key scientist from Baby KJ team launches startup to scale personalized CRISPR medicines
Aurora sets out to capitalize on FDA’s new framework for bespoke drug therapies In the News Jan 9 Written by Christine Mackenzie Christine Mackenzie
